Oral microbiome profiles by periodontitis stage in a Korean population
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1809787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Mu-Yeol Cho und 12 weiteren Autor:innen. Beteiligte Einrichtung: Apple Tree Institute of Biomedical Science, Apple Tree Medical Foundation, Goyang-si, Republic of Korea. Hauptthemen laut MEDLINE: Microbiota, Periodontitis, Bacteria, Mouth. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Periodontitis is a chronic inflammatory disease driven by oral microbial dysbiosis. Although the oral microbiome has been characterized in diverse populations, comprehensive profiling across periodontal disease stages defined by the 2018 AAP/EFP classification remains limited in Korean adults.
Methods
In this pilot prospective cross-sectional study, oral microbiome profiles were characterized in 74 participants classified into three groups: healthy controls ( n = 24), Stage I–II periodontitis ( n = 12), and Stage III–IV periodontitis ( n = 38). Mouthwash samples were collected and subjected to 16S rRNA gene sequencing of the V3–V4 hypervariable region. Alpha diversity, beta diversity (PERMANOVA with sequential covariate adjustment for age, sex, and smoking), differential abundance (MaAsLin2), and core microbiome analyses were performed.
Results
Stage III–IV periodontitis was associated with significantly higher Shannon diversity, Simpson diversity, and Pielou’s evenness compared to both healthy and Stage I–II groups, indicating increased evenness rather than species richness. Beta diversity analyses revealed significant community-level separation across groups after adjustment for demographic confounders (all p = 0.001). Differential abundance analysis identified 14 genera significantly associated with disease status. Twelve genera were enriched in Stage III–IV, including established periodontal pathogens Tannerella and Treponema, as well as emerging pathobionts Filifactor and Fretibacterium. Rothia and Kingella were enriched in periodontal health, consistent with their roles in nitrate reduction and maintenance of a health-compatible oral environment. Core microbiome analysis identified 40 universally present genera, with Anaeroglobus detected exclusively in Stage III–IV at 100% prevalence.
Conclusion
These findings support the polymicrobial synergy and dysbiosis model of periodontitis pathogenesis and provide a foundation for developing microbiome-based diagnostic tools for periodontal disease assessment in Korean populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Apple Tree Institute of Biomedical Science, Apple Tree Medical Foundation, Goyang-si, Republic of Korea.
- Apple Tree Dental Hospital, Apple Tree Medical Foundation, Goyang-si, Republic of Korea.
- Artificial Intelligence Research Center, Digital Dental Hub Incorporation, Seoul, Republic of Korea.
Zitieren
APA
Cho, M. Y., Eom, J. H., Kim, J. W., Kim, Y., Park, J. A., Kim, H. J., Lee, J. Y., Han, H. L., Ko, S. J., Her, S. B., Ko, D. Y., Kim, H. S., & Baek, H. (2026). Oral microbiome profiles by periodontitis stage in a Korean population. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1809787
Vancouver
Cho MY, Eom JH, Kim JW, Kim Y, Park JA, Kim HJ, et al. Oral microbiome profiles by periodontitis stage in a Korean population. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1809787
BibTeX
@article{Cho2026,
author = {Cho, Mu-Yeol and Eom, Je-Hyun and Kim, Ji-Won and Kim, Yunwoo and Park, Jin-Ah and Kim, Hui-Jeong and Lee, Ju-Young and Han, Hye-Lim and Ko, Se-Jeong and Her, Soo-Bok and Ko, Dong-Yub and Kim, Hye-Sung and Baek, Hanseung},
title = {Oral microbiome profiles by periodontitis stage in a Korean population},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1809787}
}
EUVIMED